Stephens Maintains Codexis Price Target at $5.00
Stephens has maintained its price target for Codexis, Inc. at $5.00 per share.
Stocks · News reference
Codexis, Inc. showcased new data at TIDES Europe 2026 demonstrating the manufacturing performance, quality, and stereo-control of its ECO Synthesis platform at the 100-gram scale.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Stephens has maintained its price target for Codexis, Inc. at $5.00 per share.
Gainers Cerenome (NASDAQ:CNSY) shares rose 39.5% to $1.07 during Friday's regular session. The market value of their outstanding shares is at $5.8 million. As per the press release, Q3 earnings came out today. SBC
Codexis announced its financial results for the third quarter ended September 30, 2026, reporting increased revenue and a narrowed net loss compared to the same period in 2025.
Filed: 2026-11-12 AccNo: 0001193125-26-458492 Size: 254 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Codexis announced a $60 million senior secured term loan agreement with Trinity Capital Inc. to refinance existing debt and support growth initiatives.
Codexis, Inc. announced a $60 million senior secured term loan agreement with Trinity Capital Inc. to refinance existing debt and provide capital flexibility for advancing its ECO Synthesis Manufacturing Platform for siRNA therapeutic manufacturing. The new facility offers 48 months of interest-only payments followed by a 12-month amortization period beginning November 2030, with post-closing outstanding debt of $42.5 million.